Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.24.1.u1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The table below presents components of stock-based compensation expense within the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income:
Thirteen Weeks Ended
in thousands March 28, 2024 March 30, 2023
General and administrative $ 6,273  $ 6,367 
Selling and store operating 959  374 
Total stock-based compensation expense $ 7,232  $ 6,741 
Stock Option Activity
The table below summarizes stock option activity for the thirteen weeks ended March 28, 2024.
Options Weighted Average Exercise Price
Outstanding at December 29, 2023
1,607,341  $ 28.51 
Exercised (170,713) $ 22.58 
Forfeited or expired (1,132) $ 92.56 
Outstanding at March 28, 2024
1,435,496  $ 29.16 
Vested and exercisable at March 28, 2024
1,419,169  $ 28.43 
Restricted Stock Unit Activity
The following table summarizes restricted stock unit activity during the thirteen weeks ended March 28, 2024:
Restricted Stock Units
Service-based Performance-based Total shareholder return Total Restricted Stock Units
Unvested at December 29, 2023 608,140  188,543  58,854  855,537 
Granted 236,678  50,855  —  287,533 
Vested (183,689) —  —  (183,689)
Forfeited (17,655) (13,001) (4,204) (34,860)
Unvested at March 28, 2024 643,474  226,397  54,650  924,521 
Restricted Stock Award Activity
The following table summarizes restricted stock award activity during the thirteen weeks ended March 28, 2024:
Restricted Stock Awards
Service-based Performance-based (1) Total shareholder return (1) Total Restricted Stock Awards
Unvested at December 29, 2023 34,783  47,662  31,056  113,501 
Vested (30,680) (47,662) (31,056) (109,398)
Forfeited (395) —  —  (395)
Unvested at March 28, 2024 3,708  —  —  3,708 
(1) The performance-based and total shareholder return restricted stock awards that vested during the period were issued at 100% of target based on achievement of the predetermined performance and total shareholder return criteria as specified in the underlying grant agreements.